R. Craig Kammerer

519 total citations
30 papers, 409 citations indexed

About

R. Craig Kammerer is a scholar working on Pharmacology, Molecular Biology and Spectroscopy. According to data from OpenAlex, R. Craig Kammerer has authored 30 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 10 papers in Molecular Biology and 10 papers in Spectroscopy. Recurrent topics in R. Craig Kammerer's work include Pharmacogenetics and Drug Metabolism (15 papers), Analytical Chemistry and Chromatography (10 papers) and Metabolomics and Mass Spectrometry Studies (7 papers). R. Craig Kammerer is often cited by papers focused on Pharmacogenetics and Drug Metabolism (15 papers), Analytical Chemistry and Chromatography (10 papers) and Metabolomics and Mass Spectrometry Studies (7 papers). R. Craig Kammerer collaborates with scholars based in United States. R. Craig Kammerer's co-authors include Debra A. Schmitz, Don H. Catlin, James L. Merdink, Caroline K. Hatton, Arthur K. Cho, Larry L. Butcher, Mark W. Dudley, T.D. Price, Thomas L. Jacobs and Richard W. Ransom and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

R. Craig Kammerer

30 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Craig Kammerer United States 12 150 138 86 77 74 30 409
Miyoshi Fukui Japan 13 202 1.3× 86 0.6× 43 0.5× 73 0.9× 28 0.4× 32 527
J.W. Kosh United States 12 158 1.1× 121 0.9× 83 1.0× 32 0.4× 43 0.6× 34 448
C. John Parli United States 15 155 1.0× 160 1.2× 105 1.2× 61 0.8× 18 0.2× 30 513
D. R. FELLER United States 13 242 1.6× 135 1.0× 68 0.8× 22 0.3× 48 0.6× 47 533
Björn Lindeke Sweden 12 119 0.8× 178 1.3× 41 0.5× 51 0.7× 28 0.4× 28 431
A. Klutch United States 10 119 0.8× 201 1.5× 22 0.3× 36 0.5× 106 1.4× 13 439
Steven M. Winter United States 9 159 1.1× 89 0.6× 29 0.3× 47 0.6× 43 0.6× 13 511
Robert J. Barnaby Italy 10 189 1.3× 40 0.3× 64 0.7× 49 0.6× 18 0.2× 20 473
A. M. Simonis Netherlands 10 258 1.7× 42 0.3× 142 1.7× 38 0.5× 23 0.3× 18 545
Hideo Yoshizumi Japan 16 213 1.4× 48 0.3× 150 1.7× 81 1.1× 24 0.3× 42 677

Countries citing papers authored by R. Craig Kammerer

Since Specialization
Citations

This map shows the geographic impact of R. Craig Kammerer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Craig Kammerer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Craig Kammerer more than expected).

Fields of papers citing papers by R. Craig Kammerer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Craig Kammerer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Craig Kammerer. The network helps show where R. Craig Kammerer may publish in the future.

Co-authorship network of co-authors of R. Craig Kammerer

This figure shows the co-authorship network connecting the top 25 collaborators of R. Craig Kammerer. A scholar is included among the top collaborators of R. Craig Kammerer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Craig Kammerer. R. Craig Kammerer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kammerer, R. Craig, et al.. (1990). Species differences in the metabolism and macromolecular binding of methapyrilene: a comparison of rat, mouse and hamster. Xenobiotica. 20(12). 1269–1280. 11 indexed citations
2.
Kammerer, R. Craig, James L. Merdink, Mark A. Jagels, Don H. Catlin, & Ka Kit Hui. (1990). Testing for fluoxymesterone (Halotestin®) administration to man: Identification of urinary metabolites by gas chromatography-mass spectrometry. Journal of Steroid Biochemistry. 36(6). 659–666. 11 indexed citations
3.
Kammerer, R. Craig & Debra A. Schmitz. (1988). A Comparativel in Vitro Metabolic Study of Methaphenilene and Pyribenzamine. Xenobiotica. 18(9). 1085–1096. 4 indexed citations
4.
Kammerer, R. Craig, et al.. (1988). Thein vivometabolism of methapyrilene, a hepatocarcinogen, in the rat. Xenobiotica. 18(7). 869–881. 9 indexed citations
5.
Kammerer, R. Craig & Marilyn A. Lampe. (1987). In vitro metabolism of chlorpheniramine in the rabbit. Biochemical Pharmacology. 36(20). 3445–3452. 5 indexed citations
6.
Kammerer, R. Craig & Debra A. Schmitz. (1987). Species differences in thein vitrometabolism of methapyrilene. Xenobiotica. 17(9). 1121–1130. 9 indexed citations
7.
Kammerer, R. Craig, et al.. (1987). Cytochrome P-450 dependent binding of methapyrilene to DNA in vitro. Carcinogenesis. 8(10). 1525–1529. 14 indexed citations
8.
Kammerer, R. Craig, et al.. (1987). The effect of chronic methapyrilene treatment on methapyrilene metabolism in vitro. Carcinogenesis. 8(2). 221–226. 5 indexed citations
9.
Kammerer, R. Craig, et al.. (1987). Synthesis of a deuterium labeled variant of the rat hepatocarcinogen, methapyrilene. Journal of Labelled Compounds and Radiopharmaceuticals. 24(12). 1469–1477. 4 indexed citations
10.
Kammerer, R. Craig & Debra A. Schmitz. (1986). Metabolism of methapyrilene by rat-liver homogenatc. Xenobiotica. 16(7). 671–680. 10 indexed citations
11.
Kammerer, R. Craig & Debra A. Schmitz. (1986). Lidocaine metabolism by rabbit-liver homogenate and detection of a new metabolite. Xenobiotica. 16(7). 681–690. 3 indexed citations
12.
Kammerer, R. Craig, et al.. (1983). Phencyclidine metabolism in vitro. The formation of a carbinolamine and its metabolites by rabbit liver preparations.. Drug Metabolism and Disposition. 11(1). 47–53. 23 indexed citations
13.
Ransom, Richard W., R. Craig Kammerer, & Arthur K. Cho. (1983). The synthesis of (3H)‐xylamine, an irreversible inhibitor of norepinephrine uptake. Journal of Labelled Compounds and Radiopharmaceuticals. 20(7). 833–841. 4 indexed citations
16.
Dudley, Mark W., et al.. (1981). The actions of xylamine on central noradrenergic neurons.. Journal of Pharmacology and Experimental Therapeutics. 217(3). 834–840. 27 indexed citations
17.
Kammerer, R. Craig, Emma DiStefano, John Jonsson, & Arthur K. Cho. (1981). Metabolism of 2-nitro-1-phenylpropane by rabbit liver microsomes. Biochemical Pharmacology. 30(16). 2257–2263. 2 indexed citations
18.
Kammerer, R. Craig, et al.. (1981). The metabolism of phencyclidine by rabbit liver preparations.. Drug Metabolism and Disposition. 9(3). 274–278. 17 indexed citations
19.
Kammerer, R. Craig, Emma Di Stefano, & Debra A. Schmitz. (1980). A Gas-Liquid Chromatography Assay for Phencyclidine and Its Metabolites. Journal of Analytical Toxicology. 4(6). 293–298. 13 indexed citations
20.
Jacobs, Thomas L. & R. Craig Kammerer. (1972). 1,3-Diadamantylallene. Trapping of a biradical intermediate in thermal dimerization of substituted allenes. Journal of the American Chemical Society. 94(20). 7190–7191. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026